Featured
Featured
ElastiMed has developed a wearable medical device, that is designed to improve circulation in the legs, for the treatment of venous and lymphatic diseases.
Based on proprietary technology, that utilizes innovative smart materials, ElastiMed’s sock compresses and massages the legs when stimulated by an electric pulse.
The smart sock is expected to provide patients with a comfortable, easy-to-wear, effective and affordable treatment option to help prevent symptoms such as swelling, blood clots, and leg ulcers.
hronic leg swelling (edema), which is caused by poor circulation, affects more than 7.4 million people in the United States alone. Edema may result from old age, cancer treatments, poor diet, or pregnancy. Blood clots, which are formed in the legs (DVT, deep vein thrombosis), affect over 790,000 people in the United States and EU. Applying constant or changing external pressure on the legs has been proven to be a highly effective treatment to improve circulation and reduce swelling. With a more than 60% non-compliance rate for existing treatment options, ElastiMed’s device is aimed at improving patient compliance with a comfortable, highly effective clinical treatment.
Breakthrough non-invasive brain neuromodulation technology. Neurolief provides a solution for the millions who suffer from the debilitating effects of migrane and depression. It enables safe and highly effective independent treatment without interference with daily activities.
Neurolief uses a cutting edge wearable neurostimulation technology. The founders are experienced in development and successful world-wide commercialization of innovative neuromodulation products.
The ReWalk™ exoskeleton suit uses patented technology with motorized legs that power knee and hip movement. Battery-powered for all-day use, ReWalk is controlled by on-board computers and motion sensors, restoring self-initiated walking without needing tethers or switches to begin stepping. ReWalk controls movement using subtle changes in center of gravity, mimics the natural gait pattern of the legs similar to that of an able-bodied person and provides functional walking speed. A forward tilt of the upper body is sensed by the system, which triggers the first step.
Repeated body shifting generates a sequence of steps which allows natural and efficient walking. The ReWalk also sits, stands, allows turning and has the ability to climb and descend stairs. Using crutches for support, you can walk and speak eye-to-eye with others in the clinic or on city streets and you can also navigate slopes and uneven terrain.
Triple Jump Israel Ltd. is an Israeli start-up company that develops an innovative Insulin Pump for diabetic patients. The company was established in April 2015, by an experienced team of experts in the insulin pump industry.
Triple Jump is currently developing a unique small insulin pump patch that is placed on the patient’s body. It has mobile connectivity capabilities and is included in a future artificial pancreas system.
Founded in March 2014, Wearable Devices LTD is an Israeli-based High-tech company developing Human-Machine Interface solutions for the Smart wearables industry.
Our vision is transforming communication via digital devices by designing them to be as natural and intuitive as human interaction. We have one granted patent, and have issued several patents in the field of wearable computing.
Our Mission is to provide the highest quality service through the development of innovative, exciting products for the Internet of Things era, focusing on Smartwatches, Virtual, Augmented and Mixed Reality industries.
We are backed by a team of highly professional business advisors and leading technological sub-contractors.
ChroniSense Medical is a young startup developing wearable health monitoring products for patient use.
Unlike the host of companies manufacturing “fitness trackers”, ChroniSense is focused on medical‑grade, regulatory-agency-approved standards of sensing and processing physiological data. Our products are designed to improve the quality of life of the chronically ill by reducing dependence on the clinic and bedside monitors.